Ernst & Young LLP’s Kim Ramko named to 2013 PharmaVOICE 100 list
New York, 1 August 2013
Ramko recognized as one of the ‘100 Most Inspiring People in the Life Sciences Industry’ by leading industry publication
Ernst & Young LLP announced today that Kim Ramko, Principal and Advisory Life Sciences Lead, has been recognized by the life sciences journal PharmaVOICE as one of the ‘100 Most Inspiring People in the Life Sciences Industry’ for 2013. Ramko was selected from a deep and impressive list of nominees for her collaborative, forward-thinking approach to solving the industry’s most complex challenges.
“Kim’s visionary leadership, innovative solutions and purpose-driven commitment to the life sciences industry are indeed inspiring,” said Bob Patton, Americas Advisory Vice Chair for the global EY organization. “Kim is a trail blazer in every possible way and we are thrilled that her groundbreaking industry collaborations and dedication to her practice and clients are being recognized.”
Nominations are submitted by the magazine's readership and editors select 100 individuals who are deemed to be a driving force in the life sciences industry.
Ramko’s currency with complex industry issues, broad management experience and strong technology background have established her as a trusted counselor to clients and a formidable leader to her colleagues. She has led the way for her team to help organizations build sustainable business models and collaborate effectively with non-traditional partners. Ramko has also made analytics a priority for the practice and has been a champion of working with clients to leverage big data as a competitive asset. As part of her selection, PharmaVOICE also highlighted Ramko’s dedication to helping women in the industry advance into positions of leadership.
“It’s truly an honor to be recognized alongside so many industry movers whom I deeply admire and respect,” said Ramko. “It is a privilege to work each day in an industry I love, with colleagues and clients who challenge me to imagine and strive towards great possibilities. Together, I’m confident we will find success in the patient-centric health care system of tomorrow.”
Prior to joining EY, Kim was the Global Life Sciences Solutions Managing Director at CSC for four years where she was responsible for global client accounts, solution development and acquisition planning along with practice management. She has over 23 years of experience managing business strategy, process improvement and large-scale information technology projects. Her areas of focus include business intelligence and analytics, health informatics, customer strategy and operational improvement and master data management.
She is a graduate of Middle Tennessee State University and is based in Nashville, Tennessee.
Ramko’s profile and the full list of recipients appear in the August 2013 issue of PharmaVOICE magazine and is available at www.pharmavoice.com.
About EY's Advisory Services
Improving business performance while managing risk is an increasingly complex business challenge. Whether your focus is on broad business transformation or more specifically on achieving growth, optimizing or protecting your business having the right advisors on your side can make all the difference. Our 30,000 advisory professionals form one of the broadest global advisory networks of any professional organization, delivering seasoned multidisciplinary teams that work with our clients to deliver a powerful and exceptional client service. We use proven, integrated methodologies to help you solve your most challenging business problems, deliver a strong performance in complex market conditions and build sustainable stakeholder confidence for the longer term. We understand that you need services that are adapted to your industry issues, so we bring our broad sector experience and deep subject matter knowledge to bear in a proactive and objective way. Above all, we are committed to measuring the gains and identifying where your strategy and change initiatives are delivering the value your business needs.
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.
EY refers to the global organization and may refer to one or more of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.
This news release has been issued by Ernst & Young LLP, an EY member firm providing services to clients in the US.